Work

Correction: SLFN11: a pan-cancer biomarker for DNA-targeted drugs sensitivity and therapeutic strategy guidance

Year: 2026

Type: erratum

Abstract: [This corrects the article DOI: 10.3389/fonc.2025.1582738.].

Source: Frontiers in Oncology

DOI: 10.3389/fonc.2026.1779304

Authors: Kunzhong Zhou, Yuewen Li, Weifang Wang, Yilin Chen, Bingyan Qian, Yiteng Liang, Hongmei Li, Ruiting Xu, Li Zhuang

Institutions: Kunming Medical University, Peking University Cancer Hospital

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,801

Funders: National Natural Science Foundation of China, Kunming Medical University

OpenAlex ID: W7127582216

Cites:

Cited by:

Related to: